T 1063/15 (RAPID DISSOLUTION FORMULATION OF CINACALCET HCl/AMGEN INC.) of 12.4.2018

European Case Law Identifier: ECLI:EP:BA:2018:T106315.20180412
Date of decision: 12 April 2018
Case number: T 1063/15
Application number: 04781429.8
IPC class: A61K 31/135
A61K 9/28
A61K 9/20
A61P 3/14
Language of proceedings: EN
Distribution: D
Download and more information:
Decision text in EN (PDF, 362 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: RAPID DISSOLUTION FORMULATION OF CINACALCET HCl
Applicant name: AMGEN INC.
Opponent name: Actavis Group PTC EHF
RAFARM S.A.
ZBM PATENTS, S.L.
Board: 3.3.07
Headnote: -
Relevant legal provisions:
European Patent Convention Art 123(3)
European Patent Convention Art 100(b)
European Patent Convention Art 56
Keywords: Extension of the scope of the claims
Sufficiency of disclosure
Inventive step
Catchwords:

-

Cited decisions:
-
Citing decisions:
T 2649/16

Source: http://www.epo.org/law-practice/case-law-appeals/recent/t151063eu1.html

Date retrieved: 17 May 2021

4 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

Case Law Book: II Conditions to be met by an Application